Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US10780105B2 · kind B2 · utility

4Cited by
2References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 20, 2018
Grant dateSep 22, 2020
Priority date
Expiry dateAug 20, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/7064
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.